BVMed Managing Director Marc-Pierre Möll made it clear that Germany is in international competition for investments and skilled workers and can only survive with competitive framework conditions in the MedTech sector. The focus is on five strategic objectives: securing the economic performance of the industry, guaranteeing healthcare, strengthening security of supply, using digitalisation and AI and expanding international competitiveness. The figures underline the importance of medical technology: the industry employs over 210,000 people and will generate a production value of around 46 billion euros in 2024, making it twice as large as the pharmaceutical industry and of central importance for the industrial healthcare sector. With the dialogue process that has now been launched, the German government wants to work together with the industry to develop a comprehensive strategy paper by 2026 that contains concrete measures on the topics of reducing bureaucracy, innovation and security of supply. This approach could rebrand Germany as a MedTech location and lead to faster implementation of medical innovations.
Press release of the "BVMed - Bundesverband Medizintechnologie e.V." from 12 November 2025